Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017505HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10018413HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10016567HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10016094HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10019538HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS30083084HIVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS30032260HIVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS30032261HIVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS30032262HIVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20005530HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TCGA Plot Options
Drug Information
GenePDE3A
DrugBank IDDB00922
Drug NameLevosimendan
Target IDBE0000436
UniProt IDQ14432
Regulation Typeinhibitor
PubMed IDs16116344
CitationsSzilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I, Papp Z: Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol. 2005 Sep;46(3):369-76.
GroupsApproved; Investigational
Direct ClassificationPhenylhydrazines
SMILESC[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Pathways
PharmGKBPA164749138
ChEMBLCHEMBL2051955